4.6 Review

Proteases and cystic fibrosis

Journal

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
Volume 40, Issue 6-7, Pages 1238-1245

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.biocel.2008.03.003

Keywords

cystic fibrosis; neutrophil elastase

Funding

  1. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065611, R01HL082504, R01HL081763, R01HL073174] Funding Source: NIH RePORTER
  2. NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016836] Funding Source: NIH RePORTER
  3. NHLBI NIH HHS [HL073174, R01 HL081763, R01 HL073174, R01 HL082504, R01 HL081763-02, R01 HL065611, HL081763, HL65611, HL082504, R01 HL082504-03, R01 HL073174-04] Funding Source: Medline
  4. NIEHS NIH HHS [R01 ES016836] Funding Source: Medline

Ask authors/readers for more resources

Cystic fibrosis is the most common, inherited fatal disease in Caucasians. The major cause of morbidity and mortality is chronic lung disease due to infection and inflammation in the airways leading to bronchiectasis and respiratory failure. The signature pathologic features of CF lung disease including abnormal mucus obstructing airways, chronic infection with Staphylococcus aureus, Pseudomonas aeruginosa and other gram negative bacteria, and a robust neutrophil-dominant airway inflammation, are exacerbated by unopposed proteases present at high concentrations in the ASL There is strong evidence that proteases, particularly neutrophil elastase, contribute to the pathology of CF by impairing mucociliary clearance, interfering with innate immune functions, and perpetuating neutrophilic inflammation. The mechanisms employed by proteases to impact air-way function in CF will be reviewed. (c) 2008 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available